● Recruiting

AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia

Condition: Community-acquired Pneumonia · Sponsor: University of Manitoba

PhasePhase 3

Planned participants4000

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

This is an international, open-label, stratified randomized controlled trial with Bayesian adaptive stopping rules to compare the effects of therapeutic-dose heparin vs. usual care pharmacological thromboprophylaxis on outcomes in patients admitted to hospital with community acquired pneumonia (CAP).

This description comes directly from the study's public registry record.

Talk to the study team

Chantale Pineau · 2042353223 · attacc.cap@umanitoba.ca

Always discuss trial participation with your own doctor first.

Locations (64)

University of Chicago	Chicago, Illinois, United States	Not Yet Recruiting
Ochsner Clinic	Jefferson, Louisiana, United States	Recruiting
Maine Medical Centre	Portland, Maine, United States	Recruiting
Henry Ford Health System	Dearborn, Michigan, United States	Completed
Cooper University Health Care	Camden, New Jersey, United States	Recruiting
Medical College of Wisconsin	Milwaukee, Wisconsin, United States	Recruiting
Hospital Estadual Dr. Jayme Santos Neves	Serra, Espírito Santo, Brazil	Recruiting
Hospital Evangelico de Vila Velha	Vila Velha, Espírito Santo, Brazil	Recruiting
Hospital Universitário Cassiano Antonio Moraes	Vitória, Espírito Santo, Brazil	Not Yet Recruiting
Santa Casa de Misericordia de Itabuna	Itabuna, Estado de Bahia, Brazil	Completed
Hospital Brasilia	Brasília, Federal District, Brazil	Completed
Hospital Sao Brasilia	Brasília, Federal District, Brazil	Not Yet Recruiting

+ 52 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05848713